挖掘药物诱导的血小板缺血的原因:一个案例报告
Vivian A Pham1, Christopher Selby2,3
1From CHI Baylor St. Luke's Medical Center, Houston, Texas.
Journal of the advanced practitioner in oncology
|April 14, 2025
概括
急性血小板减少,即血小板数量低,可能源于免疫系统的破坏. 确定特定的免疫机制对于治疗患有恶性瘤的患者至关重要,例如清细胞细胞癌.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 血小板缺血呈现出各种不同的病因,包括免疫介导的血小板破坏.
- 了解免疫性血栓缩机制对于有效治疗至关重要,特别是在癌症患者中.
- 准确的诊断指导治疗计划的伴随性疾病和血小板损失.
研究的目的:
- 在患有转移性清细胞癌的患者中报告急性血小板缩病例.
- 突出在血小板衰竭中识别免疫媒介破坏途径的重要性.
- 讨论癌症患者与并发的血液问题管理的影响.
主要方法:
- 案例报告的呈现方式.
- 审查患者的临床病史和实验室发现.
- 讨论免疫血小板缺血的诊断挑战.
主要成果:
- 一名患有转移性清晰细胞细胞癌的患者出现了急性血小板缺血症.
- 血小板破坏的潜在机制需要仔细的诊断评估.
- 这一案例强调了管理具有血液学并发症的恶性瘤的复杂性.
结论:
- 免疫介导的血小板缺血需要精确的病因学诊断,以实现最佳的患者管理.
- 早期识别免疫破坏途径对于瘤患者的治疗决策至关重要.
- 这一案例强调了在复杂的临床场景中需要彻底的诊断方法.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Drug Toxicity: Dose-Dependent Reactions
229
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229
Drug toxicity: Idiosyncratic Reactions
220
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482


